drugset / Trial / NCT02948660

A Promising Tool for Predicting Consciousness Evolution in Prolonged Disorders of Consciousness

NCT02948660

Non-randomizedParallel-groupSingle-blindScreening

Summary

The research contains two parts. Part 1: To explore whether EEG responses to zolpidem can assess consciousness circuit integrity and predict the evolution of consciousness in patients with prolonged disorders of consciousness; Part 2: To explore if quantitative EEG reactivity might predict the prognosis of disorders of consciousness.

Timeline

Start
2017-12-01
Primary completion
2019-06-30
Completion
2019-06-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Zolpidem Small molecule 10 mg

Indications